default author photo

Rong-Juan Pei

Chinese Academy of Sciences (CAS) - Wuhan Institute of Virology

Jiangxia, Hubei

China

SCHOLARLY PAPERS

1

DOWNLOADS

121

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III Trial

Number of pages: 37 Posted: 25 Mar 2022
Fudan University - Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Aga Khan University - Section of Infectious Diseases, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Centre for Clinical Medicine and Research, Walter Sisulu University - Head of Pulmonology, Shifa International Hospital, Moti Lal Nehru Medical College, Sultan Abdulhamid Han Education and Research Hospital, Dow University of Health Sciences, Dow University of Health Sciences, Hospital Kuala Lumpur - Clinical Research Centre, Fudan University, Ministry of Health Malaysia - Hospital Sungai Buloh, Chinese Academy of Sciences (CAS) - Wuhan Institute of Virology, Guangzhou Medical University - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Chinese Academy of Sciences (CAS) - Center for Emerging Infectious Diseases and Joincare Pharmaceutical Industry Group Co Ltd
Downloads 121 (592,433)
Citation 1

Abstract:

Loading...

Key Words: Efficacy, Heterologous boosting, Subunit vaccine, Clinical trial